Speaker illustration

Doctor Chien-Yi Hsu

Taipei Medical University Hospital, Taipei (Taiwan)

Director of the Heart Failure Program, Division of Cardiology and Cardiovascular Research Center, Taipei Medical University Hospital Attending Physician, Division of Cardiology, Department of Internal Medicine, Taipei Medical University Hospital. Assistant Professor, School of Medicine, College of Medicine, Taipei Medical University Ph.D., Institute of Clinical Medicine, National Yang-Ming University, Taipei, Taiwan.

Real world experience on angiotensin receptor and neprilysin inhibition in reduced ejection fraction heart failure patients with advanced chronic kidney disease

Event: ESC CONGRESS 2020 - The Digital Experience

Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)

Session: Chronic Heart Failure ePosters

Thumbnail

Effect of de-escalated switching dual antiplatelet therapy after acute myocardial infarction in patients undergoing percutaneous coronary intervention: real-world data from a nationwide cohort study

Event: ESC CONGRESS 2019

Topic: Antiplatelet Drugs

Session: Evolving developments in anti-platelet therapy

Thumbnail

Effects of sacubitril/valsartan on real-world patients with heart failure due to non-ischemic cardiomyopathy

Event: Heart Failure 2019 - 6th World Congress on Acute Heart Failure

Topic: Pharmacotherapy

Session: Chronic Heart Failure – Treatment

Thumbnail

Real world experience on angiotensin receptor and neprilysin inhibition in reduced ejection fraction heart failure patients with advanced chronic kidney disease

Event: ESC Asia with APSC & AFC 2020

Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)

Session: Abstract Programme

Thumbnail

This platform is supported by

logo Novo Nordisk